Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin remineralization is a complex physiological and therapeutic process characterized by the restoration of mineral ions, primarily carbonated hydroxyapatite, into the demineralized organic matrix of dentin. Unlike the highly inorganic enamel, dentin consists of a substantial organic framework, approximately 90% of which is Type I collagen, which serves as a scaffold for mineral deposition. This process is orchestrated by non-collagenous proteins (NCPs), particularly members of the Small Integrin-Binding Ligand N-linked Glycoprotein (SIBLING) family such as Dentin Matrix Protein 1 (DMP1) and Dentin Sialophosphoprotein (DSPP), which facilitate calcium and phosphate nucleation. In therapeutic contexts, dentin remineralization is the primary objective for treating dental caries and dentin hypersensitivity. Drugs and biomaterials target this process by providing mineral precursors or mimicking the function of natural NCPs to promote intrafibrillar mineralization, which is essential for restoring the mechanical integrity and functionality of the tooth structure. Effective remineralization also often requires the inhibition of endogenous matrix metalloproteinases (MMPs) and cysteine cathepsins that would otherwise degrade the collagen scaffold. Advanced biomimetic strategies increasingly focus on stabilizing amorphous calcium phosphate (ACP) nanoprecursors to allow for deep penetration and crystallization within the collagen fibrils.
Promotion of intrafibrillar hydroxyapatite crystallization through the stabilization of liquid-like amorphous calcium phosphate (ACP) nanoprecursors; epitaxial growth of hydroxyapatite crystals on residual mineral seeds within the dentin matrix; template-driven nucleation of minerals via biomimetic analogs of non-collagenous proteins; inhibition of endogenous collagenolytic enzymes (MMPs and cathepsins) to preserve the organic scaffold; physical occlusion of dentinal tubules via mineral precipitation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin remineralization.